This article provides a comprehensive guide for researchers and drug development professionals on validating Molecular Dynamics (MD) simulations against experimental binding data.
This article provides a comprehensive analysis of molecular docking software's accuracy and reliability in predicting drug-target interactions for cancer therapy.
This article provides a comprehensive comparative analysis of artificial intelligence (AI) models transforming anticancer drug discovery.
This article provides a comprehensive guide for researchers and drug development professionals on the critical process of validating computational drug activity predictions with experimental IC50 values.
This article provides a comprehensive overview of the methodologies, applications, and validation frameworks for computational models in cancer target identification.
Accurate prediction of PROTAC-mediated ternary complex structures is a pivotal yet formidable challenge in rational degrader design.
This article provides a comprehensive overview of cutting-edge computational and AI-driven strategies developed to target traditionally undruggable cancer proteins.
Protein function is governed by dynamic conformational changes, not static structures, making the accurate handling of flexibility a central challenge in molecular dynamics (MD).
Accurately predicting ligand binding to flexible sites remains a significant challenge in structure-based drug discovery.
This comprehensive review explores the evolving role of molecular dynamics (MD) simulations in characterizing DNA-intercalator interactions, a critical area for anticancer drug development.